| clinical trial | Q30612 |
| P3098 | ClinicalTrials.gov ID | NCT03052608 |
| P6099 | clinical trial phase | phase III clinical trial | Q42824827 |
| P17 | country | Japan | Q17 |
| United States of America | Q30 | ||
| Canada | Q16 | ||
| Spain | Q29 | ||
| Belgium | Q31 | ||
| Italy | Q38 | ||
| Poland | Q36 | ||
| Turkey | Q43 | ||
| Netherlands | Q55 | ||
| Mexico | Q96 | ||
| Singapore | Q334 | ||
| Germany | Q183 | ||
| France | Q142 | ||
| Australia | Q408 | ||
| Taiwan | Q865 | ||
| United Kingdom | Q145 | ||
| Argentina | Q414 | ||
| India | Q668 | ||
| P582 | end time | 2020-12-31 | |
| P131 | located in the administrative territorial entity | Hong Kong | Q8646 |
| P2899 | minimum age | 18 | |
| P1132 | number of participants | 280 | |
| P6153 | research site | Barcelona Province | Q81949 |
| Institut Gustave Roussy | Q266227 | ||
| University Hospital Heidelberg | Q324206 | ||
| Kanazawa University | Q684783 | ||
| Complutense University of Madrid | Q219694 | ||
| Massachusetts General Hospital | Q126412 | ||
| University of Washington | Q219563 | ||
| Yonsei University | Q39988 | ||
| Nagoya University | Q1191132 | ||
| Ege University | Q1297001 | ||
| National Taiwan University Hospital | Q1418766 | ||
| hôpital Foch | Q3145155 | ||
| Massachusetts Eye and Ear Infirmary | Q6784269 | ||
| National University Hospital | Q6979219 | ||
| Shanghai Chest Hospital | Q10867899 | ||
| Osaka City General Hospital | Q11440681 | ||
| Shizuoka Cancer Center | Q11663219 | ||
| Taichung Veterans General Hospital | Q15901822 | ||
| Azienda Ospedaliero Universitaria Maggiore della Carita | Q30254121 | ||
| Sarah Cannon Research Institute | Q30270369 | ||
| Tennessee Oncology | Q46992910 | ||
| National Cancer Center Hospital East | Q55454195 | ||
| Nou Hospital de Sant Pau | Q64443878 | ||
| Institut Paoli-Calmettes | Q3151784 | ||
| Clínica Universidad de Navarra | Q3297837 | ||
| Humanitas Research Hospital | Q3803602 | ||
| Seoul National University Hospital | Q4403855 | ||
| Asan Medical Center | Q4803501 | ||
| Central Manchester University Hospitals NHS Foundation Trust | Q5061394 | ||
| The Christie NHS Foundation Trust | Q5110676 | ||
| Hospital Universitario Puerta de Hierro Majadahonda | Q5661215 | ||
| Manchester University | Q6747552 | ||
| ??? | Q2945711 | ||
| P580 | start time | 2017-04-14 | |
| P8363 | study type | interventional study | Q78089383 |
| P1476 | title | A PHASE 3, RANDOMIZED, OPEN-LABEL STUDY OF LORLATINIB (PF-06463922) MONOTHERAPY VERSUS CRIZOTINIB MONOTHERAPY IN THE FIRST-LINE TREATMENT OF PATIENTS WITH ADVANCED ALK-POSITIVE NON-SMALL CELL LUNG CANCER |